191 related articles for article (PubMed ID: 8235701)
1. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
[No Abstract] [Full Text] [Related]
2. Optimizing treatment for chronic myeloid leukemia.
Goldman JM
N Engl J Med; 1997 Jul; 337(4):270-1. PubMed ID: 9227935
[No Abstract] [Full Text] [Related]
3. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
Guilhot F; Chastang C; Michallet M; Guerci A; Harousseau JL; Maloisel F; Bouabdallah R; Guyotat D; Cheron N; Nicolini F; Abgrall JF; Tanzer J
N Engl J Med; 1997 Jul; 337(4):223-9. PubMed ID: 9227927
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.
Patel T; Roychowdhury DF
N Engl J Med; 1997 Nov; 337(22):1634-5. PubMed ID: 9411231
[No Abstract] [Full Text] [Related]
6. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
Kantarjian HM; Talpaz M
Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
[No Abstract] [Full Text] [Related]
7. [Interferon therapy for chronic myelogenous leukemia].
Shibata A; Hashimoto S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
[TBL] [Abstract][Full Text] [Related]
8. [Chronic myeloid leukemia. What's in the future therapy in Black Africa?].
Dokekias AE; Malanda F; Mbalawa ChG
Tunis Med; 2003 Mar; 81(3):172-9. PubMed ID: 12793067
[No Abstract] [Full Text] [Related]
9. A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.
Guilhot F; Lamagnère JP; Harousseau JL; Tilly H; Casassus P; Ifrah N; Rochant H; Bauters F; Dine G; Tanzer J
Eur J Cancer; 1991; 27 Suppl 4():S26. PubMed ID: 1799470
[No Abstract] [Full Text] [Related]
10. Interferon alfa-2a for chronic myeloid leukemia.
Kennedy BJ
N Engl J Med; 1994 Aug; 331(6):402. PubMed ID: 8028628
[No Abstract] [Full Text] [Related]
11. Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia.
Benelux CML Study Group
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S19-20. PubMed ID: 8769694
[No Abstract] [Full Text] [Related]
12. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Ezaki K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
[No Abstract] [Full Text] [Related]
13. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
[No Abstract] [Full Text] [Related]
14. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
15. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for chronic myelogenous leukemia with interferon alfa and other cytokines.
Kloke O
Semin Hematol; 1993 Jul; 30(3 Suppl 3):22-3. PubMed ID: 8235699
[No Abstract] [Full Text] [Related]
17. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Boqué C; Grañena A
Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
[No Abstract] [Full Text] [Related]
18. Interferon-alpha-2 (IFN) plus hydroxyurea for treatment of juvenile chronic myelogenous leukemia.
Suttorp M; Rister M; Schmitz N
Med Pediatr Oncol; 1994; 22(5):358-9. PubMed ID: 8127262
[No Abstract] [Full Text] [Related]
19. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
[TBL] [Abstract][Full Text] [Related]
20. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
